Fingerprint
Dive into the research topics of 'Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial
Jan Hamouz, Agnieszka Nowosielska, Anna Święch-Zubilewicz, Santiago Abengoechea, Kristine Baumane, Attila Vajas, Małgorzata Siewierska, Milan Veselovsky, Miroslav Veith, Ágnes Kerényi, Shobhana Mange, Krishnapada Baidya, Guna Laganovska, Ignasi Jürgens, András Papp, Jignesh Gosai, Jana Štefanickova, Mei Han, Piotr Fryczkowski, Dominik Zalewski
Research output: Contribution to journal › Article › peer-review